Your browser doesn't support javascript.
loading
Indications and Outcomes of Laser Retinopexy in Eyes With High-Risk Lattice Degeneration.
Kazan, Adina S; Mahmoudzadeh, Raziyeh; Salabati, Mirataollah; Sharpe, James; Fineman, Mitchell S; Hsu, Jason; Yonekawa, Yoshihiro; Spirn, Marc J.
Afiliação
  • Kazan AS; Thomas Jefferson University Sidney Kimmel Medical College, Philadelphia, PA, USA.
  • Mahmoudzadeh R; Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PA, USA.
  • Salabati M; Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PA, USA.
  • Sharpe J; Biostatistics Consulting Core, Vicky and Jack Farber Vision Research Center, Wills Eye Hospital, Philadelphia, PA, USA.
  • Fineman MS; Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PA, USA.
  • Hsu J; Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PA, USA.
  • Yonekawa Y; Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PA, USA.
  • Spirn MJ; Wills Eye Hospital, Mid Atlantic Retina, Thomas Jefferson University, Philadelphia, PA, USA.
J Vitreoretin Dis ; 8(4): 381-387, 2024.
Article em En | MEDLINE | ID: mdl-39148566
ABSTRACT

Purpose:

To examine the characteristics of eyes with high-risk lattice degeneration treated with laser retinopexy and determine the indications, safety, and outcomes of the treatment.

Methods:

This interventional single-surgeon consecutive retrospective study was conducted at Wills Eye Hospital between 2014 and 2021. The series included eyes with lattice degeneration with high-risk lesions. Documented characteristics and outcomes of these eyes and fellow eyes were documented.

Results:

The study comprised 167 eyes of 143 patients (53.3% women; mean age [±SD], 50 ± 17 years). Complications after laser treatment included new posterior vitreous detachment (PVD) (n = 21), epiretinal membrane (ERM) (n = 13), retinal detachment (RD) (n = 5), and additional laser required (n = 22). Eyes that developed ERMs were more likely to develop PVDs (odds ratio, 5.39; 95% CI, 1.57-18.47). Patents who developed ERMs were older (mean, 60 ± 7 years vs 49 ± 17 years; P = .016), as were those developing PVDs (mean, 59 ± 8 years vs 48 ± 17; P = .005). No eye with a new ERM required surgery (n = 13). Four eyes with a new RD required laser retinopexy alone; 1 eye was treated surgically. No eye had an RD at the most recent evaluation.

Conclusions:

Despite high-risk lesions in areas of lattice degeneration, few eyes developed RDs after prophylactic laser retinopexy. Older patients may have a higher risk for ERM or PVD after laser treatment. Eyes with post-laser PVD were more likely to develop an ERM.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article